Rivaroxaban vs. Warfarin for Treatment of DVT and PE.

Corey Lyon,Seth Mathern,Jessica Devitt,Kristen DeSanto

AMERICAN FAMILY PHYSICIAN（2017）

Cited 24|Views2

No score

Abstract

Rivaroxaban, along with the other factor Xa inhibitors, is as effective as or better in the short term (three months) than warfarin (Coumadin) for preventing recurrent DVT, nonfatal PE, and fatal PE, with no differences in mortality or bleeding events.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined